Factors affecting the yield of cold-adapted influenza virus vaccine

Journal of Virological Methods

Volumn 64, Issue 2, 1997, Pages 161-169

  Yannarell, Dean A ^a   Hjorth, Richard N ^b  

^a WYETH AYERST RESEARCH   (United States)

^b Wyeth Lederle Vaccines and Pediat   (United States)

Author keywords

cold adapted; influenza; reassortant; yield

Indexed keywords

INFLUENZA VACCINE;

ADAPTATION; ANIMAL CELL; ARTICLE; COLD EXPOSURE; CONTROLLED STUDY; EGG; INFLUENZA VIRUS; NONHUMAN; PRIORITY JOURNAL; VACCINATION; VACCINE PRODUCTION; VIRUS; VIRUS MUTANT;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; CELL LINE; CELLS, CULTURED; CHICK EMBRYO; CHICKENS; COLD; DOGS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS; INFLUENZA VACCINES; MUTATION; PLAQUE ASSAY;

ANIMALIA; INFLUENZA VIRUS;

EID: 0030892637     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(96)02156-8     Document Type: Article

References (33)

1. Check, W.A. (1984) Renewed control efforts emphasize 'unrecognized' influenza threat. J. Am. Med. Assoc. 251, 2629-2637.
2. Clements, M.L., Sears, S.D., Christina, K., Murphy, B.R. and Snyder, M.H. (1989) Comparison of the virologic and immunologic responses of volunteers to live avian-human influenza A H3N2 reassortant virus vaccines derived from two different avian influenza virus donors. J. Clin. Microbiol. 27, 219-222.
3. Clover, R.D., Crawford, S., Glezen, W.P., Taber, L.H., Matson, C.C. and Couch, R.B. (1991) Comparison of heterotypic protection against influenza A/Taiwan/86 (H1N1) by attenuated and inactivated vaccines to A/Chile/83-like viruses. J. Infect. Dis. 163, 300-304.
4. Cox, N.J., Maassab, H.F. and Kendal, A.P. (1979) Comparative studies of wild-type and cold-mutant (temperature-sensitive) influenza viruses: nonrandom reassortment of genes during preparation of five virus vaccine candidates by recombination at 25°C between recent H3N2 and H1N1 epidemic strains and cold-adapted A/Ann Arbor/6/60. Virology 97, 190-194.
5. Davenport, F.M., Hennessy, A.V., Maassab, H.F., Minuse, E., Clark, L.C., Abrams, G.D. and Mitchell, J.R. (1977) Pilot studies on recombinant cold-adapted live type A and B influenza virus vaccines. J. Infect. Dis. 136, 17-25.
6. Dowdle, W.R. and Schild, G.C. (1975) Laboratory propagation of human influenza viruses, experimental host range, and isolation from clinical material. In: E.D. Kilbourne (Ed.), The Influenza Viruses and Influenza, Academic Press, New York, pp. 243-268.
7. Edwards, K.M., King, J.C., Steinhoff, M.C., Thompson, J., Clements, M.L., Wright, P.P. and Murphy, B.R. (1991) Safety and immunogenicity of live attenuated cold-adapted influenza B/Ann Arbor/1/86 reassortant virus vaccine in infants and children. J. Infect. Dis. 163, 740-745.
8. Fazekas de St. Groth, S. and Tees, R. (1975) Skim passage: A rapid method of adapting influenza viruses to new host tissues. Intervirology 5, 335-341.
9. Ganguly, R. and Cameron, D. (1989) Factors affecting immunization rate in a cohort of elderly veterans: a retrospective pilot study of influenza vaccine compliance. Vaccine 7, 462-464.
10. Govaert, Th.M.E., Sprenger, M.J.W., Dinant, G.J., Aretz, K., Masurel, N. and Knottnerus, J.A. (1994) Immune response to influenza vaccination of elderly people. A randomized double-blind placebo-controlled trial. Vaccine 12, 1185-1189.
11. Gruber, W.C., Hinson, H.P., Holland, K.L., Thompson, J.M., Reed, G.W. and Wright, P.F. (1993) Comparative trial of large-particle aerosol and nose drop administration of live attenuated influenza vaccines. J. Infect. Dis. 168, 1282-1285.
12. Hjorth, R.N., Bonde, G.M., Piner, E.D., Goldberg, K.M., Teller, D.M., Hite, M., Vernon, S.K., Levner, M.H. and Hung, P.P. (1991) Influenza vaccines and the Wyeth-Ayerst experience with Syntex adjuvant. In G. Gregoriadis et al. (Eds.), Vaccines, Plenum, New York, pp. 43-58.
13. Johnson, P.R., Feldman, S., Thompson, J.M., Mahoney, J.D. and Wright, P.F. (1986) Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine. J. Infect. Dis. 154, 121-127.
14. Kärber, G. (1931) Beitrag zur kollektiver behandlung pharmokologischer reihenversuche. Arch. Exp. Pathol. Pharmacol. 162, 480-483.
15. Katz, S.L. (1985) New vaccine development establishing priorities, Vol. 1. Diseases of importance in the United States. National Academy Press, Washington, pp. 342-364.
16. Klenk, H.D., Rott, R. and Orlich, M. (1977) Further studies on the activation of influenza virus by proteolytic cleavage of the haemagglutinin. J. Gen. Virol. 36, 151-161.
17. Lazarowitz, S.G., Compans, R.W. and Choppin, P.W. (1973) Proteolytic cleavage of the hemagglutinin polypeptide of influenza virus. Function of the uncleaved polypeptide HA. Virology 52, 199-212.
18. Lazarowitz, S.G. and Choppin, P.W. (1975) Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide. Virology 68, 440-454.
19. Maassab, H.F. (1967) Adaptation and growth characteristics of influenza viruses at 25°C. Nature 213, 612-614.
20. Maassab, H.F. (1969) Biologic and immunologic characteristics of cold-adapted influenza viruses. J. Immunol. 102, 728-732.
21. Maassab, H.F. and DeBorde, D.C. (1985) Development and characterization of cold-adapted viruses for use as live virus vaccines. Vaccine 3, 355-369.
22. Milliken, S. (1967) A delay in maturation as a cause of small plaque size with the NM strain of influenza A virus. J. Gen. Virol. 1, 189-198.
23. Mills, J. and Chanock, R.M. (1971) Temperature-sensitive mutants of influenza virus. I. Behavior in tissue culture and in experimental animals. J. Infect. Dis. 123, 145-157.
24. Mostow, S.R. (1986) Influenza - a preventable disease not being prevented. Am. Rev. Respir. Dis. 134,1.
25. Newman, R.W., Jennings, R., Major, D.L., Robertson, J. S., Jerkins, R., Potter, C.W., Burnett, I., Jewes, L., Anders, M., Jackson, D. and Oxford, J. S. (1993) Immune response of human volunteers and animals to vaccination with egg-grown influenza A (H1N1) virus is influenced by three amino acid substitutions in the haemagglutinin molecule. Vaccine 11, 400-406.
26. Robertson, J.S., Bootman, J.S., Nicolson, C., Major, D., Robertson, E.W. and Wood, J.M. (1990) The hemagglutinin of influenza B virus present in clinical material is a single species identical to that of mammalian cell-grown virus. Virology 179, 35-40.
27. Robertson, J.S., Nicolson, C., Bootman, J.S., Major, D., Robertson, E.W. and Wood, J.M. (1991) Sequence analysis of the haemagglutinin (HA) of influenza A (H1N1) viruses present in clinical material and comparison with the HA of laboratory-derived virus. J. Gen. Virol. 72, 2671-2677.
28. Robertson, J.S., Nicolson, C., Newman, R., Major, D., Dunleavy, U. and Wood, J.M. (1992) High growth reassortant influenza vaccine viruses: new approaches to their control. Biologicals 20, 213-220.
29. Robertson, J.S. (1993) Clinical influenza virus and the embryonated hen's egg. Rev. Med. Virol. 3, 97-106.
30. Robertson, J.S., Cook, P., Nicolson, C., Newman, R. and Wood, J.M. (1994) Mixed populations in influenza virus vaccine strains. Vaccine 12, 1317-1322.
31. Snyder, M.H., Buckler-White, A.J., London, W.T., Tierney, E.L. and Murphy, B.R. (1987) The avian influenza virus nucleoprotein gene and a specific constellation of avian and human virus polymerase genes each specify attenuation of avian-human influenza A/Pintail/79 reassortant viruses for monkeys. J. Virol. 61, 2857-2863.
32. Steinhoff, M.C., Halsey, N.A., Wilson, M.H., Burns, B.A., Samorodin, R.K., Fries, L.F., Murphy, B.R. and Clements, M.L. (1990) Comparison of live attenuated cold-adapted and avian-human influenza A/Bethesda/85 (H3N2) reassortant virus vaccines in infants and children. J. Infect. Dis. 162, 394-401.
33. Treanor, J.J., Mattison, H.R., Dumyati, G., Yinnon, A., Erb, S., O'Brien, D., Dolin, R. and Betts, R.F. (1992) Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly. Ann. Intern. Med. 117, 625-633.